Australia approves swine flu vaccine; trials in pregnant women in US
This article was originally published in SRA
Executive Summary
Pharmaceutical companies around the world are making progress in tackling the 2009 H1N1 influenza (swine flu) virus. Australia’s Therapeutic Goods Administration is the latest regulatory authority to grant approval to an H1N1 vaccine1,2. Approval was granted using the so-called progressive assessment process, whereby the TGA analysed data on a rolling basis as they became available.
You may also be interested in...
First Oral Treatment For Spinal Muscular Atrophy Gets EMA Nod
New treatments for advanced endometrial cancer and hereditary angioedema are among six drugs that have just been recommended for EU-wide approval. Harmonized EU advice has also been issued in relation to an investigational antibody combination for treating COVID-19.
EMA Works On Defining Metadata From RWD Sources
As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.
EU Decision Time On Expanded Use Of BMS/Ipsen Pharma Cancer Drug Combo
The European Medicines Agency may decide this week on a dozen requests by companies seeking new uses of their approved drugs.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: